TRYGAPOCE
LIVE

Serial Number

98225248

Owner

Ionis Pharmaceuticals, Inc.

Attorney

Brian Focarino

Filing Date

Oct 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TRYGAPOCE Trademark

Serial Number: 98225248

TRYGAPOCE is a trademark filed by Ionis Pharmaceuticals, Inc. on October 16, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ionis Pharmaceuticals, Inc. (8 trademarks)

2855 Gazelle Court
Carlsbad, CA 92010

Entity Type: 03

Trademark Details

Filing Date

October 16, 2023

Registration Date

Not Registered

Published for Opposition

July 16, 2024

Goods & Services

Medical services; medical information services; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders; medical consulting services in the field of genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of genetic diseases and disorders, and collecting data and information on genetic diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of genetic diseases and disorders; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; medical consulting services in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, and collecting data and information on cardiovascular, metabolic, neurological and inflammatory diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of cardiovascular, metabolic, neurological and inflammatory diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2026 EXRA
SOU EXTENSION 3 GRANTED
Mar 5, 2026 EX3G
SOU EXTENSION 3 FILED
Mar 5, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 5, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2026 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 14, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 13, 2025 EX2G
SOU EXTENSION 2 FILED
Aug 13, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2025 EXRA
SOU EXTENSION 1 GRANTED
Feb 18, 2025 EX1G
SOU EXTENSION 1 FILED
Feb 18, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 18, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 25, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 25, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 25, 2024 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 10, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 2, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 23, 2023 NWOS
NEW APPLICATION ENTERED
Oct 19, 2023 NWAP